CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 107 enrolled
Drug / intervention
Transcranial direct current stimulation (tDCS) Soterix Medical Inc. tDCS unit +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02155946
NCT02155946N/ACompleted

Promoting Adaptive Neuroplasticity in Mild Cognitive Impairment

VA Office of Research and Development·interventional·Posted Jun 4, 2014·Updated Nov 30, 2023

In Brief

A clinical study evaluating Transcranial direct current stimulation (tDCS) Soterix Medical Inc. tDCS unit for Mild Cognitive Impairment and Alzheimer's Disease. Completed, enrolled 107 participants across 1 site.

Detailed Summary

The aging US population threatens to overwhelm our healthcare infrastructure, especially since the rate of Alzheimer's disease (AD) alone is expected to triple in the coming decades. Memory cause functional impairment, reduced quality of life, increased caregiver burnout, and eventual institutionalization. The diagnosis of mild cognitive impairment (MCI) identifies those with memory deficits but who remain relatively independent in everyday life. MCI provides a window for interventions that target memory functioning. The proposed study focuses specifically on a groundbreaking combination of mnemonic rehabilitation and non-invasive brain stimulation. The main idea is that brain stimulation can enhance functioning in the specific brain regions/networks, thereby increasing the patients' ability to benefit from different types of memory rehabilitation. This will be a randomized, double-blind study (active vs. fake brain stimulation), that provides multiple treatment session. Outcome will be examined using both laboratory-based and real-world memory testing as well as brain imaging. This first-of-its-kind study has the potential to meaningfully translate more "basic" science findings into neuroanatomically targeted and functionally meaningful treatments for our aging population.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedJun 4, 2014
Enrollment StartDec 1, 2014
Primary CompletionFeb 28, 2021
Study CompletionMar 31, 2021
TodayJul 2, 2026
Enrollment to primary: 6.2 yearsPosted 12.1 years ago

Interventions

Transcranial direct current stimulation (tDCS) Soterix Medical Inc. tDCS unitdevice

Active brain stimulation

Transcranial direct current stimulation (tDCS) Soterix Medical Inc. tDCS unitdevice

Sham (placebo)